Rare blood clot from AstraZeneca`s COVID-19 vaccine poses high risk of death

UK researchers have found that although the syndrome - vaccine-induced immune thrombocytopenia and thrombosis (VITT) - occurs in just one out of 50,000 cases, those who do get it have a very low chance of survival.